The global healthcare M&A landscape in 2026 sits at an unusual juncture. The wider economy is facing a lot of headwinds and feels increasingly uncertain, whilst the usual private equity strategies aren’t working as smoothly as before. Healthcare is still seen as one of the strongest sectors to invest in around the world, however, and may even benefit from the shift away from software and tech-enabled services.



